All Stories

  1. Automated preparation for identification and antimicrobial susceptibility testing: evaluation of a research use only prototype, the BD Kiestra IdentifA/SusceptA system
  2. Digital imaging for reading of direct rapid antibiotic susceptibility tests from positive blood cultures
  3. Accelerated carbapenemase detection and classification
  4. Activity of Cefepime-Zidebactam against Multidrug-Resistant (MDR) Gram-Negative Pathogens
  5. An Improved Extended-Spectrum-β-Lactamase Detection Test Utilizing Aztreonam plus Clavulanate
  6. High-Stringency Evaluation of the Automated BD Phoenix CPO Detect and Rapidec Carba NP Tests for Detection and Classification of Carbapenemases
  7. The Immaculate Carbapenemase Study
  8. IMP-27, a Unique Metallo-β-Lactamase Identified in Geographically Distinct Isolates of Proteus mirabilis
  9. A Novel Topical Combination Ointment with Antimicrobial Activity against Methicillin-Resistant Staphylococcus aureus, Gram-Negative Superbugs, Yeasts, and Dermatophytic Fungi
  10. Coproduction of KPC-18 and VIM-1 Carbapenemases by Enterobacter cloacae: Implications for Newer β-Lactam–β-Lactamase Inhibitor Combinations
  11. Rosco Neo-Rapid CARB kit
  12. Indirect Tris-EDTA Disk Testing Using Imipenem and Meropenem for Detection of OXA-48 Carbapenemase Production
  13. Identification of Gram-Negative Bacteria and Genetic Resistance Determinants from Positive Blood Culture Broths by Use of the Verigene Gram-Negative Blood Culture Multiplex Microarray-Based Molecular Assay
  14. Lowering of Third Generation Cephalosporin Breakpoints
  15. Activity of Tedizolid (TR-700) against Well-Characterized Methicillin-Resistant Staphylococcus aureus Strains of Diverse Epidemiological Origins
  16. Double-Carbapenem Therapy Not Proven To Be More Active than Carbapenem Monotherapy against KPC-Positive Klebsiella pneumoniae
  17. KPC Screening by Updated BD Phoenix and Vitek 2 Automated Systems: Table 1.
  18. Extended-Spectrum- -Lactamase, AmpC, and Carbapenemase Issues
  19. First Report of CTX-M-14 Producing Clinical Isolates of Salmonella serovar Typhimurium from Egypt.
  20. Positive Extended-Spectrum- -Lactamase (ESBL) Screening Results May Be Due to AmpC  -Lactamases More Often than to ESBLs
  21. Irreproducible piperacillin/tazobactam minimum inhibitory concentrations in microdilution tests with Escherichia coli strains
  22. Convenient Test Using a Combination of Chelating Agents for Detection of Metallo- -Lactamases in the Clinical Laboratory
  23. P2031 In vitro activity of tigecycline against multidrug–resistant Acinetobacter baumannii and enhanced susceptibility to amikacin selected by exposure to tigecycline
  24. Klebsiella pneumoniae Isolate Producing at Least Eight Different β-Lactamases, Including AmpC and KPC β-Lactamases
  25. In vitro development of resistance to DX-619 and other quinolones in enterococci
  26. Prevalence of Newer  -Lactamases in Gram-Negative Clinical Isolates Collected in the United States from 2001 to 2002
  27. First Occurrence of a Pseudomonas aeruginosa Isolate in the United States Producing an IMP Metallo-β-Lactamase, IMP-18
  28. AmpC Disk Test for Detection of Plasmid-Mediated AmpC  -Lactamases in Enterobacteriaceae Lacking Chromosomal AmpC  -Lactamases